Structure

Physi-Chem Properties

Molecular Weight:  582.27
Volume:  605.675
LogP:  4.629
LogD:  3.761
LogS:  -2.104
# Rotatable Bonds:  9
TPSA:  101.44
# H-Bond Aceptor:  8
# H-Bond Donor:  4
# Rings:  6
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.197
Synthetic Accessibility Score:  3.637
Fsp3:  0.314
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.968
MDCK Permeability:  9.837562174652703e-06
Pgp-inhibitor:  0.96
Pgp-substrate:  0.849
Human Intestinal Absorption (HIA):  0.007
20% Bioavailability (F20%):  0.388
30% Bioavailability (F30%):  0.988

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.028
Plasma Protein Binding (PPB):  85.22110748291016%
Volume Distribution (VD):  0.66
Pgp-substrate:  3.463437795639038%

ADMET: Metabolism

CYP1A2-inhibitor:  0.087
CYP1A2-substrate:  0.942
CYP2C19-inhibitor:  0.24
CYP2C19-substrate:  0.796
CYP2C9-inhibitor:  0.041
CYP2C9-substrate:  0.311
CYP2D6-inhibitor:  0.088
CYP2D6-substrate:  0.962
CYP3A4-inhibitor:  0.132
CYP3A4-substrate:  0.935

ADMET: Excretion

Clearance (CL):  4.745
Half-life (T1/2):  0.447

ADMET: Toxicity

hERG Blockers:  0.932
Human Hepatotoxicity (H-HT):  0.37
Drug-inuced Liver Injury (DILI):  0.509
AMES Toxicity:  0.256
Rat Oral Acute Toxicity:  0.289
Maximum Recommended Daily Dose:  0.996
Skin Sensitization:  0.918
Carcinogencity:  0.02
Eye Corrosion:  0.003
Eye Irritation:  0.004
Respiratory Toxicity:  0.498

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC475215

Natural Product ID:  NPC475215
Common Name*:   Costaricine
IUPAC Name:   (1R)-1-[[4-[5-[[(1R)-7-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl]-2-methoxyphenoxy]phenyl]methyl]-6-methoxy-1,2,3,4-tetrahydroisoquinolin-7-ol
Synonyms:  
Standard InCHIKey:  DLKOEMSGKYGCFE-FQLXRVMXSA-N
Standard InCHI:  InChI=1S/C35H38N2O6/c1-40-32-9-6-22(15-29-27-20-31(39)34(42-3)18-24(27)11-13-37-29)16-35(32)43-25-7-4-21(5-8-25)14-28-26-19-30(38)33(41-2)17-23(26)10-12-36-28/h4-9,16-20,28-29,36-39H,10-15H2,1-3H3/t28-,29-/m1/s1
SMILES:  COC1=C(C=C(C=C1)CC2C3=CC(=C(C=C3CCN2)OC)O)OC4=CC=C(C=C4)CC5C6=CC(=C(C=C6CCN5)OC)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL501222
PubChem CID:   10325943
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0002566] Isoquinolines and derivatives
        • [CHEMONTID:0000054] Benzylisoquinolines

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32610 nectandra salicifolia Species Lauraceae Eukaryota trunk bark lower montane rainforest in Costa Rica n.a. PMID[8786363]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 0.05 ug.mL-1 PMID[453073]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 0.294 ug.mL-1 PMID[453073]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC475215 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC108434
0.962 High Similarity NPC240841
0.962 High Similarity NPC256012
0.962 High Similarity NPC42549
0.962 High Similarity NPC250846
0.962 High Similarity NPC317272
0.962 High Similarity NPC268503
0.9494 High Similarity NPC475393
0.929 High Similarity NPC48490
0.929 High Similarity NPC82457
0.929 High Similarity NPC11296
0.929 High Similarity NPC175890
0.929 High Similarity NPC274661
0.9235 High Similarity NPC191132
0.9235 High Similarity NPC60295
0.9193 High Similarity NPC121275
0.9193 High Similarity NPC284183
0.9193 High Similarity NPC4138
0.9177 High Similarity NPC25084
0.9177 High Similarity NPC247639
0.9048 High Similarity NPC286119
0.9045 High Similarity NPC277669
0.9045 High Similarity NPC76213
0.8994 High Similarity NPC271013
0.8994 High Similarity NPC104196
0.8994 High Similarity NPC229373
0.8994 High Similarity NPC222661
0.8994 High Similarity NPC258657
0.8994 High Similarity NPC311973
0.8994 High Similarity NPC90998
0.8994 High Similarity NPC30779
0.8994 High Similarity NPC290005
0.8994 High Similarity NPC223690
0.8994 High Similarity NPC7715
0.8994 High Similarity NPC182052
0.8994 High Similarity NPC49075
0.8994 High Similarity NPC251735
0.8994 High Similarity NPC15414
0.8994 High Similarity NPC239824
0.8994 High Similarity NPC290582
0.8994 High Similarity NPC185639
0.8994 High Similarity NPC279228
0.8994 High Similarity NPC285931
0.8994 High Similarity NPC328155
0.8994 High Similarity NPC181796
0.8994 High Similarity NPC42663
0.8994 High Similarity NPC54654
0.8994 High Similarity NPC217748
0.8994 High Similarity NPC8836
0.897 High Similarity NPC109925
0.8941 High Similarity NPC167116
0.8941 High Similarity NPC254441
0.8941 High Similarity NPC274716
0.8917 High Similarity NPC207824
0.8917 High Similarity NPC60538
0.8908 High Similarity NPC256124
0.8876 High Similarity NPC475479
0.8876 High Similarity NPC243454
0.8861 High Similarity NPC88249
0.8861 High Similarity NPC151895
0.8861 High Similarity NPC97221
0.8861 High Similarity NPC192768
0.8861 High Similarity NPC220858
0.8837 High Similarity NPC116465
0.8837 High Similarity NPC212237
0.8824 High Similarity NPC239584
0.8812 High Similarity NPC477564
0.8812 High Similarity NPC2295
0.8786 High Similarity NPC275680
0.8786 High Similarity NPC22115
0.8758 High Similarity NPC249797
0.8758 High Similarity NPC193949
0.8758 High Similarity NPC184026
0.8758 High Similarity NPC207757
0.8758 High Similarity NPC278799
0.8758 High Similarity NPC172765
0.8758 High Similarity NPC127674
0.8758 High Similarity NPC54379
0.8758 High Similarity NPC5238
0.8758 High Similarity NPC110416
0.8758 High Similarity NPC2413
0.8758 High Similarity NPC469817
0.8758 High Similarity NPC39701
0.8758 High Similarity NPC276588
0.8758 High Similarity NPC204828
0.8758 High Similarity NPC189266
0.8758 High Similarity NPC295691
0.8758 High Similarity NPC187022
0.8758 High Similarity NPC80129
0.8736 High Similarity NPC206900
0.8734 High Similarity NPC24233
0.8734 High Similarity NPC476571
0.8734 High Similarity NPC135538
0.8734 High Similarity NPC147390
0.8734 High Similarity NPC246587
0.8734 High Similarity NPC428
0.8675 High Similarity NPC476573
0.8675 High Similarity NPC35627
0.8675 High Similarity NPC81247
0.8671 High Similarity NPC95426
0.8671 High Similarity NPC302245
0.8671 High Similarity NPC179825
0.8671 High Similarity NPC191376
0.8671 High Similarity NPC321505
0.8671 High Similarity NPC16357
0.8636 High Similarity NPC478093
0.8636 High Similarity NPC24260
0.8621 High Similarity NPC65312
0.8621 High Similarity NPC139783
0.8599 High Similarity NPC294249
0.8588 High Similarity NPC478092
0.8588 High Similarity NPC30182
0.8588 High Similarity NPC473589
0.8588 High Similarity NPC478091
0.858 High Similarity NPC317145
0.858 High Similarity NPC76682
0.858 High Similarity NPC276890
0.858 High Similarity NPC10908
0.858 High Similarity NPC115284
0.858 High Similarity NPC63646
0.858 High Similarity NPC317439
0.858 High Similarity NPC198498
0.858 High Similarity NPC227060
0.8544 High Similarity NPC185838
0.8529 High Similarity NPC41376
0.8529 High Similarity NPC477020
0.8529 High Similarity NPC12424
0.8529 High Similarity NPC251580
0.8529 High Similarity NPC192135
0.8529 High Similarity NPC129518
0.8529 High Similarity NPC66341
0.8523 High Similarity NPC281581
0.8521 High Similarity NPC26240
0.8521 High Similarity NPC69712
0.8521 High Similarity NPC477562
0.8485 Intermediate Similarity NPC111485
0.8475 Intermediate Similarity NPC318805
0.8475 Intermediate Similarity NPC41122
0.8462 Intermediate Similarity NPC66573
0.8447 Intermediate Similarity NPC103379
0.8447 Intermediate Similarity NPC477565
0.843 Intermediate Similarity NPC293093
0.8418 Intermediate Similarity NPC476567
0.8418 Intermediate Similarity NPC136860
0.8418 Intermediate Similarity NPC128019
0.8393 Intermediate Similarity NPC232514
0.8393 Intermediate Similarity NPC276944
0.8393 Intermediate Similarity NPC238530
0.838 Intermediate Similarity NPC85381
0.8352 Intermediate Similarity NPC475654
0.8344 Intermediate Similarity NPC323123
0.8343 Intermediate Similarity NPC13916
0.8343 Intermediate Similarity NPC264850
0.8333 Intermediate Similarity NPC474507
0.8323 Intermediate Similarity NPC16107
0.8323 Intermediate Similarity NPC166014
0.8323 Intermediate Similarity NPC51957
0.8323 Intermediate Similarity NPC27410
0.8323 Intermediate Similarity NPC476151
0.8323 Intermediate Similarity NPC106295
0.8323 Intermediate Similarity NPC210437
0.8323 Intermediate Similarity NPC476144
0.8293 Intermediate Similarity NPC37272
0.8291 Intermediate Similarity NPC474915
0.8291 Intermediate Similarity NPC213206
0.8291 Intermediate Similarity NPC328750
0.8291 Intermediate Similarity NPC188163
0.8287 Intermediate Similarity NPC234318
0.8284 Intermediate Similarity NPC24465
0.828 Intermediate Similarity NPC211468
0.828 Intermediate Similarity NPC219233
0.828 Intermediate Similarity NPC170170
0.8272 Intermediate Similarity NPC7467
0.8253 Intermediate Similarity NPC186063
0.8253 Intermediate Similarity NPC126519
0.8253 Intermediate Similarity NPC170503
0.8253 Intermediate Similarity NPC203784
0.8246 Intermediate Similarity NPC204908
0.8246 Intermediate Similarity NPC83198
0.8239 Intermediate Similarity NPC73492
0.8239 Intermediate Similarity NPC299990
0.8229 Intermediate Similarity NPC119068
0.8229 Intermediate Similarity NPC40496
0.8228 Intermediate Similarity NPC314682
0.8225 Intermediate Similarity NPC324144
0.8221 Intermediate Similarity NPC92541
0.8218 Intermediate Similarity NPC476577
0.8218 Intermediate Similarity NPC148709
0.8218 Intermediate Similarity NPC173416
0.8217 Intermediate Similarity NPC253429
0.8192 Intermediate Similarity NPC135772
0.8192 Intermediate Similarity NPC302275
0.8187 Intermediate Similarity NPC474931
0.8187 Intermediate Similarity NPC306555
0.8187 Intermediate Similarity NPC81218
0.8187 Intermediate Similarity NPC158376
0.8187 Intermediate Similarity NPC145832
0.8187 Intermediate Similarity NPC210140
0.8187 Intermediate Similarity NPC117188
0.8187 Intermediate Similarity NPC205421

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC475215 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8994 High Similarity NPD8053 Approved
0.8994 High Similarity NPD8054 Approved
0.8758 High Similarity NPD7298 Approved
0.858 High Similarity NPD8099 Discontinued
0.858 High Similarity NPD8252 Approved
0.858 High Similarity NPD8251 Approved
0.8529 High Similarity NPD8156 Discontinued
0.8447 Intermediate Similarity NPD6031 Approved
0.8447 Intermediate Similarity NPD6030 Approved
0.8323 Intermediate Similarity NPD4584 Approved
0.8313 Intermediate Similarity NPD3845 Phase 1
0.8291 Intermediate Similarity NPD4664 Clinical (unspecified phase)
0.8242 Intermediate Similarity NPD4773 Phase 2
0.8242 Intermediate Similarity NPD4772 Phase 2
0.8229 Intermediate Similarity NPD8453 Clinical (unspecified phase)
0.8214 Intermediate Similarity NPD7833 Phase 2
0.8214 Intermediate Similarity NPD7832 Clinical (unspecified phase)
0.8214 Intermediate Similarity NPD7831 Phase 2
0.8086 Intermediate Similarity NPD2422 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD7201 Clinical (unspecified phase)
0.7965 Intermediate Similarity NPD6107 Approved
0.7941 Intermediate Similarity NPD4581 Clinical (unspecified phase)
0.7929 Intermediate Similarity NPD6818 Clinical (unspecified phase)
0.7919 Intermediate Similarity NPD4010 Discontinued
0.7879 Intermediate Similarity NPD1754 Clinical (unspecified phase)
0.7833 Intermediate Similarity NPD6851 Approved
0.7833 Intermediate Similarity NPD6853 Approved
0.7826 Intermediate Similarity NPD1632 Clinical (unspecified phase)
0.7809 Intermediate Similarity NPD6297 Approved
0.7791 Intermediate Similarity NPD4162 Approved
0.7742 Intermediate Similarity NPD7667 Clinical (unspecified phase)
0.7727 Intermediate Similarity NPD27 Approved
0.7727 Intermediate Similarity NPD2489 Approved
0.7713 Intermediate Similarity NPD8095 Phase 1
0.7711 Intermediate Similarity NPD7598 Phase 2
0.7705 Intermediate Similarity NPD7906 Approved
0.7697 Intermediate Similarity NPD5241 Discontinued
0.7692 Intermediate Similarity NPD4017 Approved
0.7683 Intermediate Similarity NPD3060 Approved
0.7679 Intermediate Similarity NPD3639 Approved
0.7679 Intermediate Similarity NPD3640 Phase 3
0.7679 Intermediate Similarity NPD3641 Approved
0.7657 Intermediate Similarity NPD7802 Discontinued
0.7654 Intermediate Similarity NPD6029 Clinical (unspecified phase)
0.7654 Intermediate Similarity NPD6028 Clinical (unspecified phase)
0.7627 Intermediate Similarity NPD2898 Approved
0.7622 Intermediate Similarity NPD7045 Clinical (unspecified phase)
0.7616 Intermediate Similarity NPD2978 Approved
0.7616 Intermediate Similarity NPD2977 Approved
0.7614 Intermediate Similarity NPD3051 Approved
0.7614 Intermediate Similarity NPD6071 Discontinued
0.7614 Intermediate Similarity NPD4166 Phase 2
0.7605 Intermediate Similarity NPD2420 Approved
0.7605 Intermediate Similarity NPD2421 Approved
0.7582 Intermediate Similarity NPD7313 Approved
0.7582 Intermediate Similarity NPD7312 Approved
0.7582 Intermediate Similarity NPD7311 Approved
0.7582 Intermediate Similarity NPD7310 Approved
0.7571 Intermediate Similarity NPD2970 Approved
0.7571 Intermediate Similarity NPD2969 Approved
0.7556 Intermediate Similarity NPD7479 Phase 2
0.7541 Intermediate Similarity NPD7309 Approved
0.7516 Intermediate Similarity NPD3055 Approved
0.7516 Intermediate Similarity NPD3053 Approved
0.7515 Intermediate Similarity NPD7153 Discontinued
0.7515 Intermediate Similarity NPD3647 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD5718 Phase 2
0.7485 Intermediate Similarity NPD5160 Discontinued
0.7484 Intermediate Similarity NPD5752 Clinical (unspecified phase)
0.7457 Intermediate Similarity NPD5720 Discontinued
0.7452 Intermediate Similarity NPD5310 Approved
0.7452 Intermediate Similarity NPD5311 Approved
0.7446 Intermediate Similarity NPD6618 Phase 2
0.7429 Intermediate Similarity NPD6788 Approved
0.7403 Intermediate Similarity NPD4873 Discontinued
0.7403 Intermediate Similarity NPD6042 Phase 2
0.7403 Intermediate Similarity NPD42 Phase 2
0.7396 Intermediate Similarity NPD3124 Discontinued
0.7391 Intermediate Similarity NPD2028 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD4578 Approved
0.7391 Intermediate Similarity NPD4577 Approved
0.7371 Intermediate Similarity NPD2560 Approved
0.7371 Intermediate Similarity NPD2563 Approved
0.7366 Intermediate Similarity NPD4663 Approved
0.7365 Intermediate Similarity NPD2460 Phase 3
0.7365 Intermediate Similarity NPD2458 Approved
0.7365 Intermediate Similarity NPD2459 Approved
0.7353 Intermediate Similarity NPD2874 Phase 2
0.7346 Intermediate Similarity NPD2674 Phase 3
0.7337 Intermediate Similarity NPD7132 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD5087 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD52 Approved
0.731 Intermediate Similarity NPD7526 Approved
0.731 Intermediate Similarity NPD7527 Clinical (unspecified phase)
0.7308 Intermediate Similarity NPD5313 Approved
0.7308 Intermediate Similarity NPD5312 Approved
0.7303 Intermediate Similarity NPD4666 Phase 3
0.7293 Intermediate Similarity NPD5602 Clinical (unspecified phase)
0.7283 Intermediate Similarity NPD7261 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD4083 Discontinued
0.7273 Intermediate Similarity NPD6895 Approved
0.7273 Intermediate Similarity NPD6896 Approved
0.7257 Intermediate Similarity NPD5722 Discontinued
0.7257 Intermediate Similarity NPD7945 Clinical (unspecified phase)
0.7251 Intermediate Similarity NPD1424 Approved
0.7251 Intermediate Similarity NPD1771 Clinical (unspecified phase)
0.7251 Intermediate Similarity NPD4160 Clinical (unspecified phase)
0.7249 Intermediate Similarity NPD2488 Approved
0.7249 Intermediate Similarity NPD2490 Approved
0.7247 Intermediate Similarity NPD5709 Phase 3
0.7246 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.7243 Intermediate Similarity NPD3936 Clinical (unspecified phase)
0.7239 Intermediate Similarity NPD3530 Approved
0.7239 Intermediate Similarity NPD3532 Approved
0.7239 Intermediate Similarity NPD4475 Approved
0.7239 Intermediate Similarity NPD3531 Approved
0.7239 Intermediate Similarity NPD4474 Approved
0.7235 Intermediate Similarity NPD6783 Clinical (unspecified phase)
0.7229 Intermediate Similarity NPD2156 Approved
0.7229 Intermediate Similarity NPD2154 Approved
0.7229 Intermediate Similarity NPD2155 Approved
0.7222 Intermediate Similarity NPD2669 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD6748 Discontinued
0.7219 Intermediate Similarity NPD3977 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD6658 Clinical (unspecified phase)
0.7213 Intermediate Similarity NPD5095 Phase 3
0.7213 Intermediate Similarity NPD5096 Phase 3
0.7213 Intermediate Similarity NPD3933 Discontinued
0.7212 Intermediate Similarity NPD5314 Approved
0.7212 Intermediate Similarity NPD3054 Approved
0.7212 Intermediate Similarity NPD3052 Approved
0.7212 Intermediate Similarity NPD823 Approved
0.7212 Intermediate Similarity NPD817 Approved
0.7212 Intermediate Similarity NPD2653 Approved
0.7209 Intermediate Similarity NPD5261 Clinical (unspecified phase)
0.7202 Intermediate Similarity NPD7037 Approved
0.7184 Intermediate Similarity NPD6523 Clinical (unspecified phase)
0.7178 Intermediate Similarity NPD3145 Approved
0.7178 Intermediate Similarity NPD3144 Approved
0.7176 Intermediate Similarity NPD2677 Approved
0.7168 Intermediate Similarity NPD2122 Discontinued
0.7168 Intermediate Similarity NPD5976 Discontinued
0.716 Intermediate Similarity NPD5061 Approved
0.716 Intermediate Similarity NPD5062 Approved
0.7158 Intermediate Similarity NPD5525 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD3536 Discontinued
0.7151 Intermediate Similarity NPD4123 Phase 3
0.7143 Intermediate Similarity NPD8149 Discontinued
0.7143 Intermediate Similarity NPD7291 Discontinued
0.7143 Intermediate Similarity NPD4481 Phase 3
0.7134 Intermediate Similarity NPD554 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD3686 Approved
0.7126 Intermediate Similarity NPD3687 Approved
0.7122 Intermediate Similarity NPD8318 Clinical (unspecified phase)
0.7119 Intermediate Similarity NPD5773 Approved
0.7119 Intermediate Similarity NPD5772 Approved
0.7112 Intermediate Similarity NPD3534 Clinical (unspecified phase)
0.711 Intermediate Similarity NPD6090 Discontinued
0.7105 Intermediate Similarity NPD6377 Clinical (unspecified phase)
0.7097 Intermediate Similarity NPD7038 Approved
0.7097 Intermediate Similarity NPD7039 Approved
0.7091 Intermediate Similarity NPD3061 Approved
0.7091 Intermediate Similarity NPD3059 Approved
0.7091 Intermediate Similarity NPD3062 Approved
0.7083 Intermediate Similarity NPD3156 Discontinued
0.7079 Intermediate Similarity NPD7827 Phase 1
0.7076 Intermediate Similarity NPD3692 Discontinued
0.7073 Intermediate Similarity NPD6812 Clinical (unspecified phase)
0.7073 Intermediate Similarity NPD3056 Clinical (unspecified phase)
0.7071 Intermediate Similarity NPD4040 Phase 1
0.7069 Intermediate Similarity NPD4727 Phase 1
0.7065 Intermediate Similarity NPD5708 Clinical (unspecified phase)
0.7062 Intermediate Similarity NPD7034 Discontinued
0.7059 Intermediate Similarity NPD5177 Phase 3
0.7052 Intermediate Similarity NPD7447 Phase 1
0.7039 Intermediate Similarity NPD7773 Phase 2
0.7037 Intermediate Similarity NPD6584 Phase 3
0.703 Intermediate Similarity NPD1132 Approved
0.703 Intermediate Similarity NPD1136 Approved
0.703 Intermediate Similarity NPD1130 Approved
0.7024 Intermediate Similarity NPD7425 Clinical (unspecified phase)
0.7024 Intermediate Similarity NPD1753 Discontinued
0.7019 Intermediate Similarity NPD7258 Clinical (unspecified phase)
0.7018 Intermediate Similarity NPD6331 Phase 2
0.7006 Intermediate Similarity NPD7110 Phase 1
0.7006 Intermediate Similarity NPD7109 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD6072 Discontinued
0.7006 Intermediate Similarity NPD7438 Suspended
0.7005 Intermediate Similarity NPD2494 Approved
0.7005 Intermediate Similarity NPD2493 Approved
0.7005 Intermediate Similarity NPD3452 Approved
0.7005 Intermediate Similarity NPD3450 Approved
0.7 Intermediate Similarity NPD8005 Clinical (unspecified phase)
0.6994 Remote Similarity NPD1774 Approved
0.6994 Remote Similarity NPD6087 Phase 1
0.6988 Remote Similarity NPD3109 Approved
0.6988 Remote Similarity NPD3110 Approved
0.6977 Remote Similarity NPD8131 Suspended
0.6977 Remote Similarity NPD5307 Clinical (unspecified phase)
0.6977 Remote Similarity NPD5084 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data